Longitudinal stability of HyperSightTM-CBCT based radiomic features in patients with CT guided adaptive SBRT for prostate cancer https://www.nature.com/articles/s41598-025-99920-x
Discover the world at Altruu, The Discovery Engine
Longitudinal stability of HyperSightTM-CBCT based radiomic features in patients with CT guided adaptive SBRT for prostate cancer https://www.nature.com/articles/s41598-025-99920-x
Integrating clinical and technological perspectives to enhance predictive modeling in prostate cancer surgery https://www.nature.com/articles/s41391-025-00978-5
Predisposition to prostate cancer and clinical implications in a real-life cohort https://www.nature.com/articles/s41431-025-01859-0
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial https://www.nature.com/articles/s41391-025-00975-8
Effective reduction of unnecessary biopsies through a deep-learning-assisted aggressive prostate cancer detector https://www.nature.com/articles/s41598-025-99795-y